Abstract:  “Most people with bipolar disorder spend a significant percentage of their lifetime experiencing either subsyndromal depressive symptoms or major depressive episodes, which contribute greatly to the high levels of disability and mortality associated with the disorder. Despite the importance of bipolar depression, there are only a small number of recognised treatment options available. Consecutive treatment failures can quickly exhaust these options leading to treatment-resistant bipolar depression (TRBD). Remarkably few studies have evaluated TRBD and those available lack a comprehensive definition of multi-therapy-resistant bipolar depression (MTRBD).Aims: To reach consensus regarding threshold definitions criteria for TRBD and MTRBD. ……..

TRBD criteria in bipolar depression was defined as failure to reach sustained symptomatic remission for 8 consecutive weeks after two different treatment trials, at adequate therapeutic doses, with at least two recommended monotherapy treatments or at least one monotherapy treatment and another combination treatment. MTRBD included the same initial definition as TRBD, with the addition of failure of at least one trial with an antidepressant, a psychological treatment and a course of electroconvulsive therapy.

The proposed TRBD and MTRBD criteria may provide an important signpost to help clinicians, researchers and stakeholders in judging how and when to consider new non-standard treatments. However, some challenging diagnostic and therapeutic issues were identified in the consensus process that need further evaluation and research.”

 

Hidalgo-Mazzei D, Berk M, Cipriani A, Cleare AJ, lorio AD, Dietch D, Geddes JR, Goodwin GM, Grunze H, Hayes JF, Jones I, Kasper S, Macritchie K, AcAllister-Williams RH, Morriss R, Nayrouz S, Pappa S, Soares JC, Smith DJ, Suppes T, Talbot P, Vieta E, Watson S, Yatham LN, Young AH, Stokes PRA: Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definition. British J. Psychiatry, doi: 10.1192/bjp.2018.257. [Epub ahead of print, Dec. 6, 2018].

 

https://www.ncbi.nlm.nih.gov/pubmed/30520709

Posted in Uncategorized | Comments Off on Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definition

Abstract: “The discovery of the mechanisms underlying light-gated ion channels called channel rhodospins and the subsequent development of optogenetics illustrates how breakthroughs in science and technology can span multiple levels of scientific inquiry. Our knowledge of how channelrhodopsins work emerged from research at the microscopic level that investigated the structure and function of algal proteins. Optogenetics, on the other hand, exploits the power of channelrhodospins and similar proteins to investigate phenomena at the supra-macroscopic level, notably the neural circuits involved in animal behavior that may be relevant for understanding neuropsychiatric disease. This article is being published to celebrate Peter Hegemann, Karl Deisseroth and Ed Boyden receiving a 2018 Canada Gairdner International Award “for the discovery of light-gated ion channel mechanisms, and for the discovery of optogenetics, a technology that has revolutionized neuroscience”.”

Josselyn SA:The past, present and future of light-gated ion channels and optogenetics. Elife.  2018 Oct 22;7. pii: e42367. doi: 10.7554/eLife.42367.

https://www.ncbi.nlm.nih.gov/pubmed/30343681

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197853/pdf/elife-42367.pdf

Posted in Uncategorized | Comments Off on The past, present and future of light-gated ion channels and optogenetics

Obsessive-compulsive disorder (OCD) is associated with increased mortality, but the causes of this increase are poorly understood. This study by Isomura and colleagues examined whether OCD is associated with increased risk of metabolic and cardiovascular complications.

Subjects diagnosed with OCD (n = 25,415) were identified and studied from a cohort of 12,497,002 individuals living in Sweden between 1973 and 2013. Results showed that OCD was associated with higher risk of metabolic/cardiovascular complications compared with the general population and their unaffected siblings. In the sibling comparison analysis, OCD patients had higher risks of obesity, type 2 diabetes mellitus, and circulatory system diseases. Compared with patients who were not taking serotonin reuptake inhibitors, patients taking higher doses of serotonin reuptake inhibitors and who had a longer duration of treatment had significantly lower risks of metabolic and cardiovascular complications, regardless of whether they were also taking antipsychotics. The authors concluded that OCD is associated with an increased risk of metabolic and cardiovascular complications. They also recommended monitoring of metabolic and cardiovascular health in patients with OCD early in the course of the disorder.

Isomura K, Brander G, Chang Z, Kuja-Halkola R, Rück C, Hellner C, Lichtenstein P, Larsson H, Mataix-Cols D, Fernández de la Cruz L: Metabolic and Cardiovascular Complications in Obsessive-Compulsive Disorder: A Total population, Sibling Comparison Study With Long-Term Follow-up. Biological Psychiatry 84(5): 324-331 (2018).

https://www.ncbi.nlm.nih.gov/pubmed/29395042

Posted in Uncategorized | Comments Off on Metabolic and Cardiovascular Complications in Obsessive-Compulsive Disorder: A Total Population, Sibling Comparison Study with Long-Term Follow-up

Abstract:Attention deficit/hyperactivity disorder (ADHD) is a highly heritable childhood behavioral disorder affecting 5% of children and 2.5% of adults. Common genetic variants contribute substantially to ADHD susceptibility, but no variants have been robustly associated with ADHD. We report a genome-wide association meta-analysis of 20,183 individuals diagnosed with ADHD and 35,191 controls that identifies variants surpassing genome-wide significance in 12 independent loci, finding important new information about the underlying biology of ADHD. Associations are enriched in evolutionarily constrained genomic regions and loss-of-function intolerant genes and around brain-expressed regulatory marks. Analyses of three replication studies: a cohort of individuals diagnosed with ADHD, a self-reported ADHD sample and a meta-analysis of quantitative measures of ADHD symptoms in the population, support these findings while highlighting study-specific differences on genetic overlap with educational attainment. Strong concordance with GWAS (genome-wide association study) of quantitative population measures of ADHD symptoms supports that clinical diagnosis of ADHD is an extreme expression of continuous heritable traits.”

 Demontis D, Walters RK, Martin J, Mattheisen M, Als TD, Agerbo E, Baldursson G, Belliveau R, Bybjerg-Grauholm J, Bækvad-Hansen M, Cerrato F, et al.: Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nature Genetics [Epub ahead of print, Nov. 26, 2018; doi: 10.1038/s41588-018-0269-7.  ]

https://www.ncbi.nlm.nih.gov/pubmed/30478444

Posted in Uncategorized | Comments Off on Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder

Dysregulation of the dopamine system is a well-established component of schizophrenia pathophysiology, with regional differences in dopamine targets thought to shape disease symptoms. Increased presynaptic striatal dopamine synthesis and release are among the most consistent findings in patients. These alterations seem to occur early in the disease and are also observed in prodromal subjects that are at clinically high risk for developing schizophrenia. This article is a commentary on the study by Schifani and colleagues (Brain 141(7):2213-2224, 2018) which found the first direct evidence for disrupted prefronto-cortical dopamine stress regulation in schizophrenia.

Gomes FV and Grace AA: Cortical dopamine dysregulation in schizophrenia and its link to stress. Brain 141(7): 1897-1899 (2018).

https://www.ncbi.nlm.nih.gov/pubmed/30053178

Posted in Uncategorized | Comments Off on Cortical dopamine dysregulation in schizophrenia and its link to stress

Abstract: “Heart valve disease (HVD) is a complex entity made by different pathological processes that ultimately lead to the abnormal structure and disorganization of extracellular matrix proteins resulting to dysfunction of the leaflets. At its final evolutionary step, treatments are limited to the percutaneous or surgical valve replacement, whatever the original cause of the degeneration. Understanding early molecular mechanisms that regulate valve interstitial cells remodeling and disease progression is challenging and could pave the way for future drugs aiming to prevent and/or reverse the process. Some valve degenerative processes such as the carcinoid heart disease, drug-induced valvulopathy and degenerative mitral valve disease in small-breed dogs are clearly linked to serotonin. The carcinoid heart is typically characterized by a right-sided valve dysfunction, observed in patients with carcinoid tumors developed from serotonin-producing gut enterochromaffin cells. Fenfluramine or ergot derivatives were linked to mitral and aortic valve dysfunction and share in common the pharmacological property of being 5-HT2B receptor agonists. Finally, some small-breed dogs, such as the Cavalier King Charles Spaniel are highly prone to degenerative mitral valve disease with a prevalence of 40% at 4 years-old, 70% at 7 years-old and 100% in 10-year-old animals. This degeneration has been linked to high serum serotonin, 5-HT2B receptor overexpression and SERT downregulation. Through the comprehension of serotonergic mechanisms involved into these specific situations, new therapeutic approaches could be extended to HVD in general.” Evidence also exists for pergolide and cabergoline being associated with a higher risk of cardiac valve regurgitation and pramipexole and cabergoline being associated with a higher risk of heart failure in patients with Parkinson’s disease. “This review summarizes clinical and molecular mechanisms linking the serotonergic system and heart valve disease, opening the way for future pharmacological research in the field.”

Ayme-Dietrich E, Lawson R, Da-Silva S, Mazzucotelli JP, Monassier L: Serotonin contribution to cardiac valve degeneration: new insights for novel therapies? Pharmacol. Res.  [Epub ahead of print, Sept. 9, 2018;  pii: S1043-6618(18)30587-5. doi: 10.1016/j.phrs.2018.09.009].

https://www.ncbi.nlm.nih.gov/pubmed/30208338

Posted in Uncategorized | Comments Off on Serotonin contribution to cardiac valve degeneration: new insights for novel therapies?

Abstract: “Strong evidence has emerged recently for the concept that herpes simplex virus type 1 (HSV1) is a major risk for Alzheimer’s disease. This concept proposes that latent HSV1 in brain of carriers of the type 4 allele of the apolipoprotein E gene (APOE-ε4) is reactivated intermittently by events such as immunosuppression, peripheral infection, and inflammation, the consequent damage accumulating, and culminating eventually in the development of Alzheimer’s. Population data to investigate this epidemiologically, e.g., to find if subjects treated with antivirals might be protected from developing dementia—are available in Taiwan, from the National Health Insurance Research Database, in which 99.9% of the population has been enrolled. This is being extensively mined for information on microbial infections and disease. Three publications have now appeared describing data on the development of senile dementia, and the treatment of those with marked overt signs of disease caused by varicella zoster virus (VZV), or by HSV. The striking results show that the risk of senile dementia is much greater in those who are HSV-seropositive than in seronegative subjects, and that antiviral treatment causes a dramatic decrease in number of subjects who later develop senile dementia. It should be stressed that these results apply only to those with severe cases of HSV1 or VZV infection, but when considered with the over 150 publications that strongly support an HSV1 role in Alzheimer’s, they greatly justify usage of antiherpes antivirals to treat Alzheimer’s. ….. Three indirectly relevant studies deal respectively with schizophrenia, relating to antiviral treatment to target HSV1, with the likelihood that HSV1 is a cause of fibromyalgia, and with fibromyalgia being associated with later development of senile dementia. Studies on the link between epilepsy, Alzheimer’s and herpes simplex encephalitis (HSE) are described also, as are the possible roles of APOE-ε4, HHV6 and HSV1 in epilepsy.”

Itzhaki RF: Corroboration of a Major Role for Herpes Simplex Virus Type 1 in Alzheimer’s Disease. Frontiers in Aging Neurosci., 19 October 2018 | https://doi.org/10.3389/fnagi.2018.00324

file:///C:/Users/dh/Downloads/fnagi-10-00324%20(1).pdf

Posted in Uncategorized | Comments Off on Corroboration of a Major Role for Herpes Simplex Virus Type 1 in Alzheimer’s Disease

Summary:  Light exerts a range of powerful biological effects beyond image vision, including effects on mood and learning. While the source of photic information affecting mood and cognitive functions is well established, via intrinsically photosensitive retinal ganglion cells (ipRGCs), the central mediators are unknown. Here, Fernandez and colleagues show that ipRGCs projections to the suprachiasmatic nucleus mediate the effects of light on learning, independently of the suprachiasmatic nucleus pacemaker function. However, mood regulation by light requires a suprachiasmatic nucleus-independent pathway linking ipRGCs to a previously unrecognized thalamic region, termed perihabenular nucleus. The perihabenular nucleus is integrated in a distinct circuitry with mood-regulating centers and is both necessary and sufficient for driving the effects of light on affective behavior. “Together, these results provide new insights into the neural basis required for light to influence mood and learning.”

Fernandez DC, Fogerson PM, Lazzerini Ospri L, Thomsen MB et al: Light Affects Mood and Learning through Distinct Retina-Brain Pathways. Cell 175(1): 71-84 (2018).

https://www.ncbi.nlm.nih.gov/pubmed/30173913

Posted in Uncategorized | Comments Off on Light Pathways affecting Mood and Learning

“…Immune cells normally pounce on intruding bacteria and viruses. But in multiple sclerosis (MS), immune cells target the nervous system instead. Now, researchers may have pinpointed a long-sought molecule called a self-antigen that provokes these attacks, pointing a way toward potential new treatments.”

http://www.sciencemag.org/news/2018/10/elusive-molecule-sparks-multiple-sclerosis-may-have-been-found

Specifically, guanosine diphosphate (GDP)-l-fucose synthase has been found to be an autoantigen that is recognized by cerebrospinal fluid-infiltrating CD4+ T cells from HLA-DRB3*-positive patients. Significant associations were found between reactivity to GDP-l-fucose synthase peptides and DRB3*02:02 expression, along with reactivity against an immunodominant myelin basic protein peptide. “These results, coupled with the cross-recognition of homologous peptides from gut microbiota, suggest a possible role of this antigen as an inducer or driver of pathogenic autoimmune responses in multiple sclerosis.”

Planas R, Santos R, Tomas-Ojer P, Cruciani C, Lutterotti A, Faigle W, Schaeren-Wiemers N, Espejo C, Eixarch H, Pinilla C, Martin R and Sospedra M: GDP-l-fucose synthase is a CD4+ T cell-specific autoantigen in DRB3*02:02 patients with multiple sclerosis. Science Transl. Med. 10(462). pii: eaat4301. doi: 10.1126/scitranslmed.aat4301; Oct. 10, 2018.

https://www.ncbi.nlm.nih.gov/pubmed/30305453

Posted in Uncategorized | Comments Off on Elusive molecule that sparks multiple sclerosis may have been found

Abstract: “Persistence is central to outcomes across a range of domains: the harder you try, the further you get. Yet relatively little is known about the developmental origins of persistence. Here, (Lucca and Sommerville) highlight key reasons for a surge of interest in persistence in infancy and early childhood.”

Lucca K and Sommerville JA: the Little Engine That Can: Infants’ Persistence Matters. Trends Cognitive Sci. [Epub ahead of print, August 16, 2018; pii: S1364-6613(18)30174-8. doi: 10.1016/j.tics.2018.07.012].

https://www.ncbi.nlm.nih.gov/pubmed/30122360

Posted in Uncategorized | Comments Off on Cognitive Neuroscience: Infants’ Persistence Matters